Pitfalls in diagnosing PFO: characteristics of false-negative contrast injections during transesophageal echocardiography in patients with patent foramen ovales

J Am Soc Echocardiogr. 2010 Nov;23(11):1136-42. doi: 10.1016/j.echo.2010.08.004. Epub 2010 Sep 20.

Abstract

Background: Contrast injections during transesophageal echocardiography for patent foramen ovale (PFO) detection may be false negative. The characteristics of false-negative injections were studied retrospectively.

Methods: Contrast transesophageal echocardiography was analyzed for the presence or absence of two characteristics: leftward bulging of the interatrial septum and dense contrast filling of the region of the right atrium adjacent to the interatrial septum.

Results: Two hundred forty-seven injections were administered to 14 patients with PFOs, and 130 (53%) were false negative. The absence of either characteristic during a single injection resulted in low sensitivity for PFO detection of 7%. When the two characteristics were present at the same time, the sensitivity for PFO detection after a single injection was as high as 95%.

Conclusions: The simultaneous presence of both leftward bulging of the interatrial septum and dense contrast filling of the region in the right atrium, adjacent to the interatrial septum, is a prerequisite for PFO detection, and if either characteristic is missing, the injection is inconclusive.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Analysis of Variance
  • Cohort Studies
  • Contrast Media*
  • Echocardiography, Transesophageal / adverse effects
  • Echocardiography, Transesophageal / methods*
  • False Negative Reactions
  • Female
  • Foramen Ovale, Patent / diagnostic imaging*
  • Humans
  • Image Enhancement*
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Polygeline*
  • Reference Values
  • Severity of Illness Index

Substances

  • Contrast Media
  • Polygeline